Sleeve gastrectomy for morbid obesity.

Area of Science:

• Bariatric surgery
• Surgical innovation
• Obesity treatment

Background:

• Rising prevalence of morbid obesity and super-obesity (BMI >50 kg/m2).
• Need for surgical techniques offering adequate excess weight loss (EWL) with minimal morbidity.
• Sleeve gastrectomy (SG) evolved from modifications of biliopancreatic diversion (BPD) and duodenal switch (DS).

Purpose of the Study:

• To evaluate sleeve gastrectomy (SG) as a standalone bariatric procedure.
• To highlight the benefits and potential of SG in managing morbid obesity.
• To assess SG's role as a bridge to other surgical treatments.

Main Methods:

• Review of sleeve gastrectomy (SG) history and application in bariatric surgery.
• Analysis of SG's advantages compared to other restrictive procedures.
• Consideration of laparoscopic SG performance and staged procedures.

Main Results:

• Sleeve gastrectomy (SG) demonstrates significant excess weight loss (EWL).
• SG offers benefits including low complication rates, no foreign material, preserved gastro-intestinal continuity, and no malabsorption.
• Potential superiority attributed to reduction of ghrelin-producing stomach mass.

Conclusions:

• Sleeve gastrectomy (SG) is a valuable bariatric procedure for managing morbid obesity.
• SG should be included in the surgical options for bariatric surgeons.
• Long-term studies are needed to confirm the durability of SG for sustained weight management.